These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28855400)

  • 1. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Varsavsky I; Osorio RS; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
    Neurology; 2017 Sep; 89(13):1382-1390. PubMed ID: 28855400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Osorio RS; Connaughty C; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Swerdlow RH; Brinton RD
    PLoS One; 2017; 12(10):e0185926. PubMed ID: 29016679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Rahman A; Schelbaum E; Hoffman K; Diaz I; Hristov H; Andrews R; Jett S; Jackson H; Lee A; Sarva H; Pahlajani S; Matthews D; Dyke J; de Leon MJ; Isaacson RS; Brinton RD; Mosconi L
    Neurology; 2020 Jul; 95(2):e166-e178. PubMed ID: 32580974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
    Mosconi L; Rahman A; Diaz I; Wu X; Scheyer O; Hristov HW; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
    PLoS One; 2018; 13(12):e0207885. PubMed ID: 30540774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?
    Mosconi L; McHugh PF
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):250-64. PubMed ID: 21532539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.
    Mosconi L; Murray J; Davies M; Williams S; Pirraglia E; Spector N; Tsui WH; Li Y; Butler T; Osorio RS; Glodzik L; Vallabhajosula S; McHugh P; Marmar CR; de Leon MJ
    BMJ Open; 2014 Jun; 4(6):e004850. PubMed ID: 24961717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies.
    Choi HJ; Byun MS; Yi D; Sohn BK; Lee JH; Lee JY; Kim YK; Lee DY;
    Alzheimers Res Ther; 2017 Aug; 9(1):64. PubMed ID: 28818092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.
    Oh H; Habeck C; Madison C; Jagust W
    Hum Brain Mapp; 2014 Jan; 35(1):297-308. PubMed ID: 22965806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.
    Carapelle E; Serra L; Modoni S; Falcone M; Caltagirone C; Bozzali M; Specchio LM; Avolio C
    Medicine (Baltimore); 2017 Apr; 96(16):e5876. PubMed ID: 28422821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.
    Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    JAMA Neurol; 2013 Aug; 70(8):1030-8. PubMed ID: 23797806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.